Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer. - Wikidata - awgldk - TriplyDB

Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer.

Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer.

http://www.wikidata.org/entity/Q37641611

about

Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer Future directions for the early detection of recurrent breast cancer Progesterone-targeted magnetic resonance imaging probes Optimization of the preparation of fluorine-18-labeled steroid receptor ligands 16alpha-[18F]fluoroestradiol (FES), [18F]fluoro furanyl norprogesterone (FFNP), and 16beta-[18F]fluoro-5alpha-dihydrotestosterone (FDHT) as radiopharmaceuticals.Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential.The neuropeptide y y(1) receptor: a diagnostic marker? Expression in mcf-7 breast cancer cells is down-regulated by antiestrogens in vitro and in xenografts.Longitudinal noninvasive imaging of progesterone receptor as a predictive biomarker of tumor responsiveness to estrogen deprivation therapy.Pharmacodynamic imaging guides dosing of a selective estrogen receptor degrader International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators Comparison of 18F-FES, 18F-FDG, and 18F-FMISO PET Imaging Probes for Early Prediction and Monitoring of Response to Endocrine Therapy in a Mouse Xenograft Model of ER-Positive Breast Cancer.Review: Receptor Targeted Nuclear Imaging of Breast Cancer.Overview of Genetically Engineered Mouse Models of Breast Cancer Used in Translational Biology and Drug Development.Quantitative hormone therapy follow-up in an ER+/ERαKD mouse tumor model using FDG and [11C]-methionine PET imaging.18F-16α-17β-Fluoroestradiol Binding Specificity in Estrogen Receptor-Positive Breast Cancer.Effects of letrozole on breast cancer micro-metastatic tumor growth in bone and lung in mice inoculated with murine 4T1 cells.High specific activity is not optimal: 18 F-fluoroestradio positron emission tomography-computed tomography results in a breast cancer xenograft.Determination of binding affinity of molecular imaging agents for steroid hormone receptors in breast cancer.

P2860

Q26740567-22332E44-E1C0-4C3C-8261-7BB8D8535B43 Q26772868-F4EA962A-87B9-4A11-B77A-BBC6B077A229 Q27022040-C05DA120-762E-415D-9A4C-050DD9C3A574 Q30836342-4C51EB40-FA5B-420F-86D2-DED163F91927 Q34068083-7A886036-73EE-4670-B030-1643DF29A3D7 Q34315419-0B885D15-5D5F-4B06-8838-540C4C623DD3 Q34510673-3A279D5F-42DD-4E9D-8B1B-ED99E493A541 Q35143049-46CB0168-1922-46FD-BDE4-5B383C207BCB Q35178385-7AC41E1A-39B7-420D-A663-C8A85CEC001D Q35795751-CA39B369-8A9B-4EED-AD48-EA45240981CE Q36088779-ECD58441-25FE-46A8-BEF6-1475DD683675 Q37690662-5D42BC6F-8C69-42D3-A36B-6A76950BD850 Q38578970-E8557737-5998-44C1-B406-29686ECC9E2F Q41907070-F751F174-1C0E-4513-9201-59A681F4E9A1 Q47732227-DC1A53C7-0930-414C-90A4-A54635D9F5A5 Q48226422-2E44C27C-AF89-4076-B9F5-F4FB0AAABF32 Q48301796-FCED729E-1DA3-4DFE-9BE1-CA84EF0F7F38 Q55069738-AB628EA9-ACF1-42EE-ABC3-A2CB8D8D1ABE

P2860

Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer.

http://www.wikidata.org/entity/Q37641611

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 June 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Small-animal PET of steroid ho ...... inical model of breast cancer.

@en

Small-animal PET of steroid ho ...... inical model of breast cancer.

@nl

type

label

Small-animal PET of steroid ho ...... inical model of breast cancer.

@en

Small-animal PET of steroid ho ...... inical model of breast cancer.

@nl

prefLabel

Small-animal PET of steroid ho ...... inical model of breast cancer.

@en

Small-animal PET of steroid ho ...... inical model of breast cancer.

@nl

P1433

Q37641611-FCE6DCC8-F5EC-454B-8986-40FFDD082FC7

P1476

Q37641611-71FD6F19-2811-46DC-AB6F-0E717C8372D8

P2093

Q37641611-596782FE-D939-43EE-AF9F-731DD350584C

Q37641611-59889551-0ADB-475C-A48C-15097FCCF6A9

Q37641611-5EF808B8-ECCC-4D9D-86EB-A008223F6E75

Q37641611-685EAB47-0C5B-405D-9627-4D65D3014032

Q37641611-6DB43FC4-4895-43C7-8832-0195B91F99F1

Q37641611-AC12CF37-404E-4AF8-8700-C96F8810F2FC

Q37641611-D1C46A0F-BDD9-4E73-BC4D-D0C0F86BE08B

Q37641611-D5BF6196-4E7A-48F0-99F7-E12972F99C7F

Q37641611-DA4C21F3-ED66-4693-8941-7B3290C81414

Q37641611-E4223432-A8BD-4DF5-89B9-404208A146F3

P2860

Q37641611-072F5D5D-0541-4E61-AFF4-C65974832D2E

Q37641611-253D7838-E1CF-4FE6-921F-AE6F685017CA

Q37641611-295EA15B-C4FA-4EDF-B568-199A70FC0AB4

Q37641611-34146D83-9CE5-438F-8FAD-DBC33442D243

Q37641611-39B80A9A-9CFA-4F06-9511-54EE31428ECB

Q37641611-4059E987-08CF-4948-A815-8FF6C28DB26D

Q37641611-453682D7-DAF0-4286-9939-27D5CFB17434

Q37641611-49C50B08-0C5A-4BD3-A309-3BDBED4999A2

Q37641611-5E27B686-CE09-4FF5-B6C1-C913158DE3BB

Q37641611-6EBE84E8-BB75-4013-A05A-64E15B868CD0

P304

Q37641611-01E41BBB-F45D-40FE-AC53-18F265BB1D35

P31

Q37641611-EAA4F7C9-4C8B-4CDD-80BF-02DB1F66FEAF

P356

Q37641611-95EA266D-B513-4FA5-BB33-84AA2FEEA772

P407

Q37641611-04762A9C-A9FB-42DE-89E2-9DBD0CF4CE9B

P433

Q37641611-33B94E82-A3F3-4C7C-8F6B-28758B50D509

P478

Q37641611-2FD9817B-C64B-42B4-A826-9F0AC2B4F096

P577

Q37641611-BA9CEBF6-8789-4DD9-A676-F70D8165E75E

P5875

Q37641611-8C77C395-A7F2-42CC-83B0-CFD43ECB639C

P698

Q37641611-64E0B156-7812-460F-BA7A-B9CEF346C5A4

P932

Q37641611-D93D08C3-53C3-447C-91C9-A784F24E7EAF

P356

JNUMED.112.103465

P1433

The Journal of Nuclear Medicine

P1476

Small-animal PET of steroid ho ...... inical model of breast cancer.

@en

P2093

Amy M Fowler

http://www.w3.org/2001/XMLSchema#string

Carmen S Dence

http://www.w3.org/2001/XMLSchema#string

Dong Zhou

http://www.w3.org/2001/XMLSchema#string

John A Katzenellenbogen

http://www.w3.org/2001/XMLSchema#string

Kathryn E Carlson

http://www.w3.org/2001/XMLSchema#string

M Jeyakumar

http://www.w3.org/2001/XMLSchema#string

Michael J Welch

http://www.w3.org/2001/XMLSchema#string

Nicole M Fettig

http://www.w3.org/2001/XMLSchema#string

Robert D Schreiber

http://www.w3.org/2001/XMLSchema#string

Szeman Ruby Chan

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway

Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.

Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer.

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

Is estradiol mandatory for an adequate follicular and embryo development? A mouse model using aromatase inhibitor (anastrozole)

STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas

Pure oestrogen antagonists for the treatment of advanced breast cancer.

Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione.

The use of 3-methoxymethyl-16 beta, 17 beta-epiestriol-O-cyclic sulfone as the precursor in the synthesis of F-18 16 alpha-fluoroestradiol.

Mechanisms of endocrine resistance in breast cancer.

P304

1119-1126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2967/JNUMED.112.103465

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225273386

http://www.w3.org/2001/XMLSchema#string

P698

22669982

http://www.w3.org/2001/XMLSchema#string

P932

3956595

http://www.w3.org/2001/XMLSchema#string